In addition, loss of APC and APC2 results in increased expression of the Wnt signaling target genes cMYC and Sox9 (Figure 6b), lending further weight to the clinical relevance of the loss of both genes, especially for a difficult to treat sub-population of human cancer patients. Here, MYC is linked to cancer.